News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
701,341 Results
Type
Article (41603)
Company Profile (465)
Press Release (659273)
Section
Business (208506)
Career Advice (2002)
Deals (35956)
Drug Delivery (92)
Drug Development (83316)
Employer Resources (169)
FDA (16330)
Job Trends (15047)
News (352233)
Policy (32989)
Tag
Academia (2624)
Alliances (50617)
Alzheimer's disease (1273)
Approvals (16255)
Artificial intelligence (139)
Bankruptcy (361)
Best Places to Work (11737)
Biotechnology (351)
Breast cancer (123)
Cancer (1110)
Cardiovascular disease (102)
Career advice (1671)
Cell therapy (247)
Clinical research (65999)
Collaboration (404)
Compensation (199)
COVID-19 (2591)
C-suite (100)
Data (1136)
Diabetes (156)
Diagnostics (6201)
Earnings (86114)
Employer resources (147)
Events (112973)
Executive appointments (313)
FDA (16870)
Funding (362)
Gene therapy (191)
GLP-1 (610)
Government (4408)
Healthcare (19004)
Infectious disease (2675)
Inflammatory bowel disease (113)
Interviews (308)
IPO (16578)
Job creations (3694)
Job search strategy (1428)
Layoffs (439)
Legal (7931)
Lung cancer (174)
Manufacturing (181)
Medical device (13342)
Medtech (13347)
Mergers & acquisitions (19438)
Metabolic disorders (423)
Neuroscience (1564)
NextGen Class of 2024 (6736)
Non-profit (4534)
Northern California (1494)
Obesity (242)
Opinion (198)
Patents (102)
People (57637)
Phase I (20681)
Phase II (29131)
Phase III (21549)
Pipeline (458)
Postmarket research (2590)
Preclinical (8878)
Radiopharmaceuticals (251)
Rare diseases (233)
Real estate (6002)
Regulatory (21963)
Research institute (2404)
Resumes & cover letters (351)
Southern California (1324)
Startups (3747)
United States (13803)
Vaccines (565)
Weight loss (182)
Date
Today (134)
Last 7 days (849)
Last 30 days (3846)
Last 365 days (36676)
2024 (33592)
2023 (41020)
2022 (52290)
2021 (56776)
2020 (54954)
2019 (47448)
2018 (35729)
2017 (33043)
2016 (32366)
2015 (38450)
2014 (32207)
2013 (27118)
2012 (29230)
2011 (29868)
2010 (28002)
Location
Africa (731)
Arizona (200)
Asia (38523)
Australia (6402)
California (3409)
Canada (1289)
China (250)
Colorado (146)
Connecticut (160)
Europe (84011)
Florida (458)
Georgia (116)
Illinois (351)
Indiana (198)
Kansas (99)
Maryland (588)
Massachusetts (2710)
Michigan (159)
Minnesota (277)
New Jersey (965)
New York (965)
North Carolina (754)
Northern California (1494)
Ohio (140)
Pennsylvania (847)
South America (1107)
Southern California (1324)
Texas (473)
Utah (92)
Washington State (371)
701,341 Results for "858 therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
858 Therapeutics and OpenBench Launch Small Molecule Drug Discovery Collaboration
November 4, 2024
·
2 min read
Press Releases
858 Therapeutics Announces $50 Million Series B Financing
September 27, 2024
·
3 min read
Drug Development
858 Therapeutics to Present Preclinical Data on ETX-19477 at the AACR 2024 Annual Meeting
858 Therapeutics today announced an upcoming poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2024, taking place April 5-10 in San Diego, California.
March 14, 2024
·
2 min read
BioCapital
ABMRF Invests in Amygdala Neurosciences to Develop ANS-858 for Alcohol Use Disorder
Amygdala Neurosciences announced that the Company has closed a new round of equity financing led by ABMRF, the Alcohol Beverage Medicines Research Foundation to fund the Company’s IND-stage activities for ANS-858.
May 14, 2024
·
4 min read
Business
858 Therapeutics Expands Leadership Team to Support Transition to the Clinic
858 Therapeutics is pleased to announce today that it has named Katherine Bell-McGuinn, M.D., Ph.D., as Chief Medical Officer.
December 20, 2023
·
2 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Drug Development
LAZCLUZE™ (lazertinib) Now Available from Onco360 for the First-line Treatment, in Combination with Rybrevant®, of Adult Patients with Metastatic Non-Small Cell Lung Cancer Whose Tumors Have EGFR Exon 19 Deletions or Exon 21 L858R Mutations
August 30, 2024
·
3 min read
Press Releases
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
November 13, 2024
·
4 min read
Business
Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
Gain Therapeutics, Inc. announces that Matthias Alder has departed the Company in order to pursue other opportunities.
June 27, 2024
·
5 min read
Press Releases
Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
October 8, 2024
·
14 min read
1 of 70,135
Next
